<DOC>
	<DOC>NCT00861939</DOC>
	<brief_summary>The purpose of this study is to demonstrate the relative bioequivalence of Bupropion HCI 300 mg ER Tablets under fasting conditions.</brief_summary>
	<brief_title>To Demonstrate the Relative Bioavailability of Bupropion HCI 300 mg Extended-Release Tablets Under Fasting Conditions</brief_title>
	<detailed_description />
	<mesh_term>Bupropion</mesh_term>
	<criteria>No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening. Positive test results for HIV or hepatitis B orc. Treatment for drug or alcohol dependence.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>58 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>